Suppr超能文献

CSN-CRL复合物:脂肪生成的新调节因子

CSN-CRL Complexes: New Regulators of Adipogenesis.

作者信息

Dubiel Dawadschargal, Naumann Michael, Dubiel Wolfgang

机构信息

Institute of Experimental Internal Medicine, Medical Faculty, Otto von Guericke University, Leipziger Str. 44, 39120 Magdeburg, Germany.

出版信息

Biomolecules. 2025 Mar 5;15(3):372. doi: 10.3390/biom15030372.

Abstract

Recent discoveries revealed mechanistic insights into the control of adipogenesis by the Constitutive Photomorphogenesis 9 Signalosome (CSN) and its variants, CSN and CSN, which differ in the paralog subunits, CSN7A and CSN7B. CSN and CSN variants form permanent complexes with cullin-RING-ubiquitin ligases 3 and 4A (CRL3 and CRL4A), respectively. These complexes can be found in most eukaryotic cells and represent a critical reservoir for cellular functions. In an early stage of adipogenesis, mitotic clonal expansion (MCE), CSN-CRL1, and CSN-CRL4A are blocked to ubiquitinate the cell cycle inhibitor p27, leading to cell cycle arrest. In addition, in MCE CSN-CRL complexes rearrange the cytoskeleton for adipogenic differentiation and CRL3 ubiquitylates the inhibitor of adipogenesis C/EBP homologous protein (CHOP) for degradation by the 26S proteasome, an adipogenesis-specific proteolysis. During terminal adipocyte differentiation, the CSN-CRL3 complex is recruited to a lipid droplet (LD) membrane by RAB18. Currently, the configuration of the substrate receptors of CSN-CRL3 on LDs is unclear. CSN-CRL3 is activated by neddylation on the LD membrane, an essential adipogenic step. Damage to CSN/CUL3/CUL4A genes is associated with diverse diseases, including obesity. Due to the tremendous impact of CSN-CRLs on adipogenesis, we need strategies for adequate treatment in the event of malfunctions.

摘要

最近的发现揭示了组成型光形态建成9信号体(CSN)及其变体对脂肪生成控制的机制性见解,CSN及其变体在旁系同源亚基CSN7A和CSN7B上存在差异。CSN和CSN变体分别与cullin-RING-泛素连接酶3和4A(CRL3和CRL4A)形成永久复合物。这些复合物存在于大多数真核细胞中,是细胞功能的关键储备。在脂肪生成的早期阶段,有丝分裂克隆扩增(MCE)、CSN-CRL1和CSN-CRL4A被阻断,无法使细胞周期抑制剂p27泛素化,导致细胞周期停滞。此外,在MCE中,CSN-CRL复合物重排细胞骨架以促进脂肪生成分化,CRL3使脂肪生成抑制剂C/EBP同源蛋白(CHOP)泛素化,以便通过26S蛋白酶体进行降解(一种脂肪生成特异性蛋白水解)。在终末脂肪细胞分化过程中,CSN-CRL3复合物通过RAB18被招募到脂滴(LD)膜上。目前,CSN-CRL3在LD上的底物受体的构型尚不清楚。CSN-CRL3在LD膜上通过NEDDylation激活(这是一个关键的脂肪生成步骤)。CSN/CUL3/CUL4A基因的损伤与多种疾病相关,包括肥胖症。由于CSN-CRLs对脂肪生成有巨大影响,我们需要在其功能出现故障时采取适当治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3872/11940434/e1acbd3f38e8/biomolecules-15-00372-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验